Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 19252

AbstractDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Case report
Year : 2022 | Month : April | Volume : 16 | Issue : 4 | Page : OD14 - OD15 Full Version

Mini-Crush Technique in Left Main Coronary Bifurcation: A Case Report


Published: April 1, 2022 | DOI: https://doi.org/10.7860/JCDR/2022/52212.16283
Sanjat Chiwane

1. Consultant Cardiologist, Department of Cardiology, Artemis Hospitals, Gurugram, Haryana, India.

Correspondence Address :
Sanjat Chiwane,
Consultant Cardiologist, Department of Cardiology, Artemis Hospitals,
Gurgaon, Haryana, India.
E-mail: sanjat.chiwane@gmail.com

Abstract

Percutaneous coronary intervention of Left Main (LM) coronary artery bifurcation disease remains technically challenging. Despite the plethora of techniques in current practice and guidelines advocating provisional strategy (one-stent or main branch-stent only), controversy still persists regarding the two-stent techniques.Moreover, there is improved mindfulness towards various factors affecting LM treatment such as patient selection, stent characteristics, risk stratification, optimum imaging, as well as vessel preparation. The latest generation stent with ultra-thin struts have been safe and efficient in the treatment of LM bifurcation lesions, as they have upgraded designs that aid in the expansion of their diameters to larger extent. Additionally, being ultra-thin leads to lower metal load at the carina, thus improving the long-term outcomes. The authors here present with the case of a 42-year-old patient with LM bifurcation disease who was successfully managed with mini-crush technique using ultra-thin Tetriflex Sirolimus-Eluting Stents (SES). The case depicts that optimum amalgamation of ultrathin strut stents implantation and mini-crush technique would provide very favourable results.

Keywords

Coronary angiography, Percutaneous coronary intervention, Sirolimus-eluting stents

A 42-year-old male patient presented with continuous chest pain along with breathing difficulty two days back and then underwent coronary angiography in another hospital. There, double vessel disease was diagnosed and was advised to undergo revascularisation. Therefore, he was referred to Department of Cardiology, Artemis Hospitals, Gurugram, Haryana, India and was admitted and treated with anticoagulants, antiplatelet, antianginal drugs, statins and other supportive treatment. On admission, the laboratory findings were: Total Leukocyte Count (TLC)-11,600/mm3, Haemoglobin (Hb)-14.6 g/dL, platelet count-2.57 lac per unit volume, urea/creatinine ratio-27.1 mg/dL/0.98 mg/dL, Na+/K+-135 mEq/L/3.7 mmol/L and viral marker-negative. Two-dimensional echocardiography showed presence of Regional Wall Motion Abnormality (RWMA) (mid anterio-septum, apex, mid inferio-septum, mid/distal anterior, distal inferior wall hypokinetic), 35-40% left ventricular ejection fraction, normal Right Ventricular (RV) function, Inferior Vena Cava (IVC)-1.2 cm with >50% variation. In view of significant LM-Left Anterior Descending (LAD) artery/Left Circumflex (LCX) artery stenosis (Medina class 1, 1, 1) (Table/Fig 1)(a).

Stenting to LM-LAD/LCX was planned to be done by using Tetriflex (Sahajanand Medical Technologies Ltd., Surat, India) sirolimus-eluting stents of sizes 3.0×12 mm and 3.5×24 mm. After crossing guide wire in LAD and LCX; and lesions were predilated with short length balloon (Table/Fig 1)(b,c). Then, Tetriflex stent (3.0×12 mm) was negotiated at ostium of LCX and another Tetriflex stent (3.5×24 mm) was negotiated from mid LM to proximal LAD. Subsequently, the 3.0×12 mm stent was inflated in LCX (Table/Fig 1)(d,e). After postdilatation of first stent (Table/Fig 1)(f), next stent was deployed in LM-LAD by crushing the ostium stent of LCX (Table/Fig 1)g. Following implantation, post dilatation was done with short length balloon in LCX ostium (Table/Fig 1)h and short length balloons were used as final kissing balloons (Table/Fig 1)i.

Final angiogram showed TIMI III flow representing normal epicardial perfusion (Table/Fig 1)j. Patient’s hospital stay was uneventful and and duration of stay remained for three days. On discharge, laboratory findings were: TLC-8,100 cells/mm3, Hb-19.6 g/dL, PC-1.61 per unit volume, urea/creatinine ratio-41 mg/dL /0.91 mg/dL, Na+/K+-135 mEq/L/3.8 mmol/L. The patient was discharged on medication (Ticagrelor, Aspirin, Rosuvastatin, Metoprolol, Pantoprazole, Clonazepam and Paracetamol) in stable condition and was in favourable condition at three months follow-up.

Discussion

The LM bifurcation has been the largest and most important bifurcation lesion amongst the entire coronary vasculature as it accompanies the most potential complications and adverse long-term outcomes of target vessel failure and Target Lesion Revascularisation (TLR) (1). The LM disease is seen to be significant in about 7% of total angiographies, of which around 80% lesions involve bifurcation (2). With the innovations in managing strategies through years, there has been an enormous shift from coronary artery bypass grafting towards percutaneous coronary intervention. Moreover, there is improved mindfulness towards various factors affecting LM treatment such as patient selection, risk stratification, optimum imaging, vessel preparation, and stenting techniques (1). All these together lead to optimised outcomes. From the available stenting techniques, single stent technique is the cross overprovisional technique and for double stenting: T-stenting, T and protrusion, mini-crush, culotte and mini-culotte, K crush, and nano-Crush are widely used (3). Along with stenting technique, major role is played by stent characteristics. The latest generation stent with ultra-thin struts have been safe and efficient in the treatment of LM bifurcation lesions, as they have upgraded designs that aid in the expansion of their diameters up to even 5 or 6 mm (3). Moreover, being ultra-thin leads to lower metal load at the carina thus improving the long-term outcomes. In present case, LM bifurcation disease was treated successfully with mini-crush technique using ultra-thin (60 μm) Tetriflex sirolimus-eluting stents.

However, there has been a dilemma about single stenting and double stenting in LM bifurcations. Some studies recommend provisional stenting in LM bifurcations (4),(5),(6),(7), while some lesions mandate implantation of two stents. If the length of lesion in LCX is more than 10 mm, then it is denoted as complex lesion requiring double stenting (3). Moreover, two-stent technique has been allied with maintaining better flow in main branch as well as side branch and thus leading to dodging of the occlusive event in LCX (8). However, another hurdle for two-stent technique is the variable types of techniques that are available such as T-/TAP-stenting, culotte technique, and mini-crush/double-kissing crush techniques (9). Myriad of factors affect the choice of stenting technique: caliber of the main vessel and the side branch, calcification, tortuosity, angulation between main and side branch, stent expansion capability, stent design, and stent flexibility (9),(10).

In this case, we had chosen mini-crush technique for treating LM bifurcation.Previously the crush technique was widely used for bifurcation stenting. However, the three layers of struts at the side branch ostium in crush technique posed difficulty in final kissing balloon inflation and made the procedure complex. Thus, Minicrush technique was evolved that comprised least (usually 1-2 mm) evasion of the side branch stent into the main branch, thus dodging a significant area to be covered with three layers of struts and lessening metallic stenosis at the side branch ostium (11). With passage of time, the mini-crush technique has gained much favourable outcomes as compared to other two-stent strategies. The Milan and New-Tokyo (MITO) registry (8) compared the results of culotte stenting and mini-crush techniques; reported that incidences of myocardial infarction and stent thrombosis were lower in mini-crush group (8). Moreover, the mini-crush stenting assured the patency of the main branch throughout the procedure when compared to culotte technique (8). Additionally, a recent meta-analysis that included 14 bifurcation trials with 4285 patients documented that DK crush and mini-crush techniques were associated with fewer Major Adverse Cardiac Events (MACE), Target Vessel Revascularisation (TVR), and TLR rates when compared to other bifurcation strategies (10). In parallel to the literature, the results of the present study case have been favourable without any immediate or short-term outcomes. The postprocedure TIMI III flow was achieved. Wainstein MV et al.,reported a case with variation where two-stent reverse minicrush technique with drug eluting stents was described that was applied for treatment of restenosis of ostial LCX stent (12).

To augment the favourable outcomes of the two-stent technique, the stent characteristics also play an important role. The transpiration of stent advancements into ultra-thin strut stents have been a great boon. The least thickness of struts helps in reducing turbulence of blood flow at carina, thus diminishing the rates of adverse events. The thinner stents tend to have greater elasticity, flexibility, and deliverability. Tetriflex SES is one such latest generation stent that has L-605 cobalt chromium alloy platform with a strut thickness of 60 μm. In addition to stent, the interventionists’ preference is of utmost importance that should be taken in consideration for selection of the technique as per the expertise and confidence in the chosen technique.

Conclusion

The mini-crush technique applied in the treatment of LM bifurcation lesion turns up to be very favourable approach while using an ultrathin stent. Thus, indigenous ultra-thin stents can be used in difficult approaches with ease of deliverability and would provide favourable outcomes.

References

1.
Rab T, Sheiban I, Louvard Y, Sawaya FJ, Zhang JJ, Chen SL. Current interventions for the left main bifurcation. JACC: Cardiovascular Interventions. 2017;10(9):849-65. [crossref] [PubMed]
2.
Dash D. Double kissing crush and nano crush stenting in left main coronary bifurcation lesions: Besting the rival techniques! Journal of Indian College of Cardiology. 2020;10(3):105.
3.
Rigatelli G, Zuin M, Dash D. Thin and crush: The new mantra in left main stenting? World Journal of Cardiology. 2018;10(11):191. [crossref] [PubMed]
4.
Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, et al. Very late stent thrombosis and late target lesion revascularisation after sirolimuseluting stent implantation: Five-year outcome of the j-Cypher Registry. Circulation. 2012;125(4):584-91. [crossref] [PubMed]
5.
Colombo A, Moses JW, Morice MC, Ludwig J, Holmes Jr DR, Spanos V, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation. 2004;109(10):1244-49. [crossref] [PubMed]
6.
Toyofuku M, Kimura T, Morimoto T, Hayashi Y, Ueda H, Kawai K, et al. Three-year outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease: Insights from the j-Cypher registry. Circulation. 2009;120(19):1866-74. [crossref] [PubMed]
7.
Song YB, Hahn JY, Yang JH, Choi SH, Choi JH, Lee SH, et al. Differential prognostic impact of treatment strategy among patients with left main versus non–left main bifurcation lesions undergoing percutaneous coronary intervention: Results from the COBIS (Coronary Bifurcation Stenting) Registry II. JACC: Cardiovascular Interventions. 2014;7(3):255-63. [crossref] [PubMed]
8.
Kawamoto H, Takagi K, Chieffo A, Ruparelia N, Fujino Y, Yabushita H, et al. Long term outcomes following mini crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New Tokyo (MITO) registry. Catheterization and Cardiovascular Interventions. 2017;89(1):13-24. [crossref] [PubMed]
9.
Fajadet J, Capodanno D, Stone GW. Management of left main disease: An update. European Heart Journal. 2019;40(18):1454-66. [crossref] [PubMed]
10.
Chiabrando JG, Lombardi M, Vescovo GM, Wohlford GF, Koenig RA, Abbate A, et al. Stenting techniques for coronary bifurcation lesions: Evidence from a network meta analysis of randomized clinical trials. Catheterization and Cardiovascular Interventions. 2012;97(3):E306-18. [crossref]
11.
Ahn JM, Lee PH, Park SJ. Practical based approach to left main bifurcation stenting. BMC Cardiovascular Disorders. 2016;16(1):01-08. [crossref] [PubMed]
12.
Wainstein MV, Wainstein RV, Ribeiro JP. Unprotected left main bifurcation restenosis treated with a 2 stent technique. Catheterization and Cardiovascular Interventions. 2013;82(3):E200-05. [crossref] [PubMed]

Tables and Figures
[Table / Fig - 1]
DOI and Others

DOI: 10.7860/JCDR/2022/52212.16283

Date of Submission: Sep 01, 2021
Date of Peer Review: Dec 15, 2021
Date of Acceptance: Feb 25, 2022
Date of Publishing: Apr 01, 2022

Author declaration:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Sep 02, 2021
• Manual Googling: Feb 21, 2022
• iThenticate Software: Feb 24, 2022 (9%)

Etymology: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com